SGLT2 Inhibitors and their use for preventing cardiovascular diseases.
Read More »Managing Editor, Diabetes in Control
Long-Term Lactation Benefits for Gestational Diabetes Patients
Breastfeeding has many known long-term benefits, which include the reduction of the risk of a major disease state.
Read More »Canagliflozin for Those on Triple Drug Therapy with Uncontrolled Diabetes
SGLT-2 inhibitors have proved to be successful hypoglycemics, so should they be recommended earlier for those not achieving goal A1c reductions?
Read More »Glycemic Variability (GV) Increases Risk For Poorer Outcomes
Maintaining a steady GV through lifestyle, proper treatment regimen, and responsible dietary nutrition can help manage a type 2 diabetic condition.
Read More »Medication Adherence and its Effect on Diabetes Outcomes
Is there a benefit to keeping it “simple” when determining appropriate regimens for patients with diabetes?
Read More »Qualifying for Social Security/Disability with Diabetes
Type 1 diabetes doesn’t always qualify for disability benefits, but some people are able to receive monthly disability benefits from the Social Security Administration (SSA).
Read More »How to Lower Your Premiums on Life Insurance if you have Type 2 Diabetes
Lowering your blood sugars and controlling your diabetes will earn you lower life insurance premiums. Read on to find out why and how.
Read More »Liraglutide Use in Youth with Type 2 Diabetes
Results from a phase 3 trial investigating the use of liraglutide in children and adolescents.
Read More »Can Closed Loop Systems Be Effective for Type 1 Diabetes?
Automated insulin delivery can soon replace insulin injections completely.
Read More »How Adipose Tissue Impacts Exercise Tolerance
Can the amount of fat on the heart impact a person’s tolerance for exercise?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.